Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Feng Mao Hua | M | 56 | 3 years | |
| De Min Zhou | M | 58 | 4 years | |
| Hai Feng Yang | M | 47 | 4 years | |
| Yun Yi Li | F | 44 | 4 years | |
| Yang Xu | M | 57 | 4 years | |
| Siu Kuen Lai | F | 48 | 3 years | |
| Ming Yang | M | 58 | 4 years | |
| Jing Wang | F | 42 |
Shanghai Stock Exchange
 Shanghai Stock Exchange Investment Banks/BrokersFinance Shanghai Stock Exchange provides marketplace and facilities for securities trading. Its services include formulating business rules, accepting and arranging listings, organizing and monitoring securities trading, regulating members & listed companies, managing, and disseminating market information. The company was founded on November 26, 1990 and is headquartered in Shangha, China | 4 years |
| Jiwei Wang | M | 37 | 4 years | |
| Min MIn Qin | M | 66 | 4 years | |
| Lei Fang | M | 41 | 4 years | |
| Hu Li | M | 59 | 4 years | |
| Maggie Geman Li | F | 58 | 4 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Frederick Hausheer | M | - |
BioNumerik Pharmaceuticals, Inc.
 BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology BioNumerik Pharmaceuticals, Inc. discovers and develops new medicines for cancer treatment. The firm's products include Tavocept which has the potential to substantially increase patient survival in the most common type of lung cancer and possibly many other forms of cancer, and Karenitecin which is an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company was founded by Frederick H. Hausheer on December 15, 1992 and is headquartered in San Antonio, TX. | - |
| David Margrave | M | 64 |
BioNumerik Pharmaceuticals, Inc.
BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology BioNumerik Pharmaceuticals, Inc. discovers and develops new medicines for cancer treatment. The firm's products include Tavocept which has the potential to substantially increase patient survival in the most common type of lung cancer and possibly many other forms of cancer, and Karenitecin which is an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company was founded by Frederick H. Hausheer on December 15, 1992 and is headquartered in San Antonio, TX. | 20 years |
| Sharon Langenbeck | M | - |
University of Missouri
| 9 years |
| Daniel Decker | M | 71 |
University of Missouri
| 5 years |
| Ken Green | M | 62 |
University of Missouri
| 5 years |
| Kai Jiao | M | 49 |
Shanghai Stock Exchange
Shanghai Stock Exchange Investment Banks/BrokersFinance Shanghai Stock Exchange provides marketplace and facilities for securities trading. Its services include formulating business rules, accepting and arranging listings, organizing and monitoring securities trading, regulating members & listed companies, managing, and disseminating market information. The company was founded on November 26, 1990 and is headquartered in Shangha, China | 6 years |
| Yi Peng Li | M | 47 | - | |
| Mohammed Shahidehpour | M | 68 |
University of Missouri
| 4 years |
| Razali bin Mohamed Yusof | M | 65 |
University of Missouri
| 5 years |
| Tom Ebinger | M | 69 |
University of Missouri
| 6 years |
| David L. Holder | M | - |
University of Missouri
| 6 years |
| Jung-Tak Kim | M | 70 |
University of Missouri
| 4 years |
| David E. Roth | M | - |
University of Missouri
| 4 years |
| Steven W. Fox | M | - |
University of Missouri
| 5 years |
| Bradley Stewart Hubbard | M | 66 |
University of Missouri
| 8 years |
| Steven Purvis | M | 59 |
University of Missouri
| 8 years |
| David Alan Rolfe | M | - |
University of Missouri
| 4 years |
| Murat Erten | M | - |
University of Missouri
| 1 years |
| Dennert O. Ware | M | 81 |
BioNumerik Pharmaceuticals, Inc.
BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology BioNumerik Pharmaceuticals, Inc. discovers and develops new medicines for cancer treatment. The firm's products include Tavocept which has the potential to substantially increase patient survival in the most common type of lung cancer and possibly many other forms of cancer, and Karenitecin which is an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company was founded by Frederick H. Hausheer on December 15, 1992 and is headquartered in San Antonio, TX. | - |
| Mark A. Wickert | M | - |
University of Missouri
| 3 years |
| John D. Yingling | M | - |
University of Missouri
| 4 years |
| Michael D. Stolte | M | - |
University of Missouri
| 4 years |
| Kristy Bruse | M | - |
University of Missouri
| 4 years |
| Pat Mckenzie | M | - |
University of Missouri
| 4 years |
| Mike Vandelicht | M | - |
University of Missouri
| 4 years |
| Kent B. Lina | M | - |
University of Missouri
| 4 years |
| Allison M. Murdock | F | - |
University of Missouri
| 4 years |
| Michael E. Brown | M | - |
University of Missouri
| 4 years |
| Doug Stansberry | M | - |
University of Missouri
| 4 years |
| Martin A. Rector | M | 60 |
University of Missouri
| 4 years |
| Steve Browne | M | - |
University of Missouri
| 4 years |
| Scott Douglas | M | 64 |
University of Missouri
| 4 years |
| Dan Norman Ginsparg | M | - |
University of Missouri
| 4 years |
| Stuart Woody | M | - |
University of Missouri
| 4 years |
| Jim Lumpe | M | - |
University of Missouri
| 4 years |
| Joseph D. Giesler | M | 65 |
University of Missouri
| 4 years |
| Tim Hannan | M | - |
University of Missouri
| 4 years |
| Mike G. Jonagan | M | - |
University of Missouri
| 4 years |
| Yi Chang | M | 66 |
University of Missouri
| 1 years |
| Paul Saverio Giordano | M | 61 |
University of Missouri
| 4 years |
| Brett Begemann | M | 63 |
University of Missouri
| 4 years |
| David Ayres | M | - |
University of Missouri
| 4 years |
| Bruce E. Castle | M | - |
University of Missouri
| 3 years |
| Roshan Zamir | M | 64 |
University of Missouri
| 4 years |
| Steve Kaufmann | M | - |
University of Missouri
| 4 years |
| Joel W. Jones | M | - |
University of Missouri
| 4 years |
| Salmah Mohd Taufek | F | 61 |
University of Missouri
| 4 years |
| Julie Hedges | F | - |
University of Missouri
| 4 years |
| Kamaroll Zaman bin Abdul Aziz | M | 66 |
University of Missouri
| 4 years |
| Sandra H. Magnus | M | - |
University of Missouri
| 4 years |
| Carleton Miller | M | 61 |
University of Missouri
| 4 years |
| Omar Akram Omran Al-Bitar | M | 61 |
University of Missouri
| 4 years |
| Mohsen M. Sohi | M | 65 |
University of Missouri
| 4 years |
| Neil E. Sprague | M | 69 |
University of Missouri
| 3 years |
| Francis Joseph Duff | M | - |
University of Missouri
| 4 years |
| Peter A. Ritcher | M | - |
University of Missouri
| 4 years |
| Mark D. Heffernan | M | - |
University of Missouri
| 4 years |
| Michael P. McRobert | M | 65 |
University of Missouri
| 4 years |
| Patrick K. Donnelly | M | - |
University of Missouri
| 4 years |
| Kurt Wulff | M | 59 |
University of Missouri
| 4 years |
| George E. Murray | M | - |
University of Missouri
| 3 years |
| Bartly J. Loethen | M | - |
University of Missouri
| 4 years |
| Randall Lee Barnard | M | 65 |
University of Missouri
| 4 years |
| Linda K. Pietroburgo | F | - |
University of Missouri
| 3 years |
| Karl A. Dunajcik | M | - |
University of Missouri
| 4 years |
| Peter William Tuz | M | - |
University of Missouri
| 1 years |
| Thomas Albert Schmitt | M | 67 |
University of Missouri
| 4 years |
| Donna M. Jaegers | F | - |
University of Missouri
| 3 years |
| Randall Schilling | M | 61 |
University of Missouri
| 4 years |
| Mark Lawrence Weintrub | M | 63 |
University of Missouri
| 4 years |
| Thomas V. O'Halloran | M | - |
University of Missouri
| 4 years |
| Dennis Shields | M | 67 |
Graceland University
| 4 years |
| Roger W. Ehrich | M | - |
University of Missouri
| 4 years |
| Joe Kessinger | M | - |
University of Missouri
| 4 years |
| Dane L. Cantwell | M | - |
University of Missouri
| 4 years |
| Susan Kay Regan | F | - |
University of Missouri
| 4 years |
| Darrin L. Emerick | M | - |
University of Missouri
| 4 years |
| Joseph E. Mattingly | M | 64 |
University of Missouri
| 4 years |
| Craig Calder | M | - |
University of Missouri
| 4 years |
| Gregory R. Diekemper | M | 65 |
University of Missouri
| 4 years |
| Scott Peppard | M | - |
University of Missouri
| 4 years |
| David Lorge | M | 77 |
University of Missouri
| 4 years |
| Steve Welker | M | - |
University of Missouri
| 4 years |
| Robert Sherman Tynes | M | 61 |
University of Missouri
| 4 years |
| Dan Esser | M | - |
University of Missouri
| 4 years |
| Mark A. Palmer | M | - |
University of Missouri
| 4 years |
| Cathy Dunkin | F | - |
University of Missouri
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 85 | 85.00% |
| China | 15 | 15.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Fredrick Hausheer
- Personal Network
